Related Experiment Video

Updated: Dec 23, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.3K

Intracellular mechanisms of tumor cells' immunoresistance

Justyna Hermanowicz1, Beata Sieklucka2, Krzysztof Nosek3

  • 11Department of Pharmacodynamics, Medical University of Bialystok, Białystok, Poland; 2Department of Clinical Pharmacy, Medical University of Bialystok, Białystok, Poland.

Acta Biochimica Polonica
|April 23, 2020
PubMed

Insights

Cancer cells evade immune responses by creating immunosuppressive tumors, often through immune checkpoint inhibitors like PD-1 and CTLA-4. Blocking these pathways can restore T-lymphocyte function to fight cancer.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Cancer cells utilize immune checkpoints, such as PD-1 and CTLA-4, to evade the immune system by creating an immunosuppressive tumor microenvironment.
  • These checkpoints, when activated on T lymphocytes, inhibit anti-tumor immune responses.

Purpose of the Study:

  • To investigate the role of immune checkpoints in tumor-mediated immune evasion.
  • To explore the potential of blocking immunosuppressive pathways for enhancing anti-tumor immunity.

Main Methods:

  • Analysis of immune checkpoint interactions (PD-1/PD-L1, CTLA-4/CD80/CD85).
  • Investigation of intracellular signaling pathways involved in tumor immunoresistance.
  • Evaluation of blocking immunosuppressive pathways to restore T-lymphocyte function.

Main Results:

  • Inhibition of the interaction between immune checkpoints (PD-1/CTLA-4) and their ligands (PD-L1, CD80, CD85) effectively unblocks T-lymphocyte activity.
  • Targeting specific intracellular signaling pathways contributes to overcoming tumor cell immunoresistance.
  • Blocking immunosuppressive pathways demonstrates potential for enhancing anti-tumor immune responses.

Conclusions:

  • Targeting immune checkpoints like PD-1 and CTLA-4 is a viable strategy to overcome cancer immune evasion.
  • Interfering with tumor-induced immunosuppression can reinvigorate the immune system's ability to eliminate cancer cells.
  • Further research into intracellular signaling pathways may reveal additional therapeutic targets for cancer immunotherapy.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.3K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.0K